Mark Jones
Impact in
- Oncology top 5%
- Metal complexes synthesis and properties
- Colorectal Cancer Treatments and Studies
- Organic Chemistry top 5%
- Ferrocene Chemistry and Applications
Papers in
- Co-authors
- T.A. Connors (5 shared papers)Abdul R. Khokhar (2 shared papers)P.D. Braddock (2 shared papers)M. L. TOBE (2 shared papers)Kenneth R. Harrap (5 shared papers)A H Calvert (2 shared papers)Terence R. Jones (1 shared paper)Ann L. Jackman (1 shared paper)
- Journals
- Trials (6 papers)British Journal of Cancer (4 papers)Biochemical Pharmacology (3 papers)PLoS ONE (2 papers)Transplantation (2 papers)
- Partner nations
- United KingdomAustraliaUnited States
In The Last Decade
Mark Jones
90 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 138
- Oncology 685
- Organic Chemistry 424
- Nephrology 46
- Hepatology 49
- Ophthalmology 52
Countries citing papers authored by Mark Jones
This map shows the geographic impact of Mark Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Jones more than expected).
Fields of papers citing papers by Mark Jones
This network shows the impact of papers produced by Mark Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Jones. The network helps show where Mark Jones may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Jones, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 98 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1981 | 200 | |
| 2 | 1972 | 188 | |
| 3 | 1975 | 126 | |
| 4 | A novel trans-platinum coordination complex possessing in vitro and in vivo antitumor activity. | 1994 | 116 |
| 5 | cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice. | 1997 | 105 |
| 6 | 2022 | 87 | |
| 7 | 1980 | 68 | |
| 8 | 2004 | 52 | |
| 9 | 1978 | 49 | |
| 10 | 1995 | 43 | |
| 11 | 1973 | 41 | |
| 12 | Schedule dependency of orally administered bis-acetato-ammine-dichloro-cyclohexylamine-platinum(IV) (JM216) in vivo. | 1994 | 39 |
| 13 | 2018 | 37 | |
| 14 | 2004 | 35 | |
| 15 | 1976 | 34 | |
| 16 | 1986 | 33 | |
| 17 | 1990 | 33 | |
| 18 | 2017 | 32 | |
| 19 | 2019 | 30 | |
| 20 | 1980 | 27 |
About Mark Jones
Mark Jones is a scholar working on Oncology, Surgery, Public Health, Environmental and Occupational Health, Infectious Diseases and Pulmonary and Respiratory Medicine, having authored 98 papers that have together received 1.9k indexed citations. Recurring topics across this work include Metal complexes synthesis and properties (10 papers), Viral gastroenteritis research and epidemiology (6 papers), Ferrocene Chemistry and Applications (5 papers), COVID-19 Clinical Research Studies (4 papers), Corneal surgery and disorders (4 papers), Organ Donation and Transplantation (4 papers), Acute Lymphoblastic Leukemia research (3 papers) and Intraocular Surgery and Lenses (3 papers). The work is most often cited by research in Oncology (685 citations), Organic Chemistry (424 citations), Nephrology (46 citations), Hepatology (49 citations) and Ophthalmology (52 citations). Mark Jones has collaborated with scholars based in United Kingdom, Australia and United States. Frequent co-authors include T.A. Connors, Abdul R. Khokhar, P.D. Braddock, M. L. TOBE, Kenneth R. Harrap, A H Calvert, Terence R. Jones, Ann L. Jackman, K.R. Harrap and Phyllis M. Goddard. Their work appears in journals such as Trials, British Journal of Cancer, Biochemical Pharmacology, PLoS ONE and Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.